Brief: Alpha Cognition Announces Positive Neuroprotection Data From Pre-Clinical Study Of Alpha-1062
22/02/2022 13:53
Feb 22 (Reuters) - Alpha Cognition Inc ACOG.V :
* ALPHA COGNITION ANNOUNCES POSITIVE NEUROPROTECTION DATA
FROM
PRE-CLINICAL STUDY OF ALPHA-1062 FOR TRAUMATIC BRAIN INJURY
* ALPHA COGNITION INC - TODAY'S RESULTS COMBINED WITH DATA
RELEASED PREVIOUSLY, STRONGLY SUPPORT FURTHER DEVELOPMENT OF
ALPHA-1062 FOR TREATMENT OF TBI
Source text for Eikon: ID:nBwc1YQm0a
Further company coverage: ACOG.V
((reuters.briefs@thomsonreuters.com;))
Recent news on Alpha Cognition
See all newsBrief: Alpha Cognition Announces Pricing Of $50 Million Upsized Public Offering And Nasdaq Listing
Brief: Alpha Cognition Inc - Files Registration Statement For $25 Million Offering
Brief: Alpha Cognition Announces Completion Of $4.545 Million Convertible Note And Warrants Bridge Financing
Brief: Alpha Cognition Says On Track To Secure Financing For Continued Growth
Brief: Alpha Cognition Inc Says Applied To List Common Shares On Nasdaq Under Trading Symbol “Acog”